Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The stock was sold at an ...

Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

By Michael M. Canaris Astute churchgoers likely recently noted that the weekend of Jan. 18-19 marked the Second Sunday in ...

Tempus AI product lines work in concert with one another, creating a pinwheel effect as they generate data, making it more valuable over time. The company launched its 'AI-enabled personal health ...

Analyst discusses AI stock Tempus AI, highlighting potential for profitability by 2025, insider selling, and sector risks.

Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14, 2024 ...

For the fourth quarter and full-year 2024, Tempus AI announced its preliminary revenue numbers on Jan. 13. Per the announcement, fourth-quarter preliminary revenues were around $200 million ...

TEM's Genomics unit is expected to report strong growth for the fourth quarter, banking on continued unit growth pick-up.